Longer intervals between the diagnosis of MPN or MPN/MDS and TP53 detection are associated with a worse prognosis.

Cutaneous manifestations of myelodysplastic syndrome (MDS) are described in a perspective piece published in the April issue of Skin Health and Disease. Xiang Li Tan, M.B.B.S., from St. George's ...

The Prognostic Nutritional Index (PNI) and systemic oxidative stress (SOS) score are independently associated with poorer prognosis of low-risk myelodysplastic syndrome (MDS), according to a study ...

In the largest cohort of MDS/MPN-U reported to date, JAK2 mutations were identified in 34% of patients and were associated with improved OS.

Characteristics including Ogata score and phenotypic aberrancies may correlate with mutational patterns that are predictive of treatment response in patients with myelodysplastic syndrome. The ...

Patients with MDS report more symptoms than physicians, indicating a communication gap in symptom assessment. Allogeneic hematopoietic stem cell transplantation is the only cure but is limited to ...

Patients with myelodysplastic syndrome should seek an expert opinion on their disease to ensure an accurate diagnosis and proper treatment plan. Myelodysplastic syndromes (MDS) are rare blood cancers ...

MIAMI, FLORIDA (EMBARGOED UNTIL AUG. 8, 2023 AT 10 A.M. ET) – Blood disorders known as myelodysplastic syndromes/neoplasms (MDS) are difficult to diagnose – and are commonly misdiagnosed – putting ...